We Medialis Ltd are celebrating the end of another successful year as the only #medicalaffairs consultancy and CRO. We showed why our unique approach matters in seven key research projects in 2021. Our work in 2021 on the four pillars showed how #medical affairs enhances #rwegeneration and strategy for #pharmaceuticalcompanies. With increasing payor and regulator pressure to include #RWE in #stakeholder submissions, low rates of #RWE inclusion and unsuccessful stakeholder engagements that have ended the development of several drugs in 2021… …knowing how to generate RWE for pharmaceutical stakeholders has never been so important. With the publication of seven key papers in 2021, Medialis knows rwe generation better than any other CRO, so our strategies for optimising #medicineadoption work. Generic disease-severity measurements for #raredisease #clinicaltrials don’t cut it – specific tools are needed for accurate recruitment and treatment effect measurement:
This applies to #qualityoflife measurement… https://lnkd.in/eptnfnFg
and core datasets/ disease-severity scores https://lnkd.in/gQAim7D
Stakeholders vary in their evidentiary needs, and successful RWE generation is stakeholder specific. https://lnkd.in/e7Cdd4jw
Including the right RWE reduces the time to maximal adoption by 22% and increases the depth of maximal medicine adoption by 31% https://lnkd.in/eE_Dkkf
The #Jandyalamethod creates disease-specific #QoL measurements, like the PAC19-QoL instrument and registry (NCT04586413), the first quality of life measure for Long #Covid19 https://lnkd.in/eYPXYTrA
Estimating the real-world benefits of adopting certain medical strategies can be vital to successful medicine adoption https://lnkd.in/esbCW49z
Medical affairs pharmaceutical physicians are key to the success of pharmaceutical companies due to their unique contribution to medicine adoption, as shown by the MAPPval Instrument (manuscript in press) In 2022, we want to see more RWE generated in the right way to ensure that more patients get the medicines they need, sooner.
Generate better rwe in 2022. Contact info@medialis.co.uk to find out more.
#pharmaceuticals #clinicalstudies #NeutralTheory #clinicalresearch #multiplestakeholderapproach #medicineadoptionmodel #thirty22RWEstrategy #constructmeasurement